Socialiya - Entertainment. Knowledge. Community.
‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long

The highly anticipated results of a clinical trial for the pill, daraxonrasib, have been released, g...

HEALTH NEWS May 31, 2026

‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long

The highly anticipated results of a clinical trial for the pill, daraxonrasib, have been released, giving doctors hope for treating the stubbornly lethal...

3 views 0 likes 0 comments
Share:
The highly anticipated results of a clinical trial for the pill, daraxonrasib, have been released, giving doctors hope for treating the stubbornly lethal...

Author: The Washington Post

Read Original Article

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya